
BAM FINANCIAL STATEMENT 2022-2023
BAM Financial Statement
BAM Financial Statement
The Life Science Strategy was developed through extensive consultation with Manitoba’s bioscience community, in collaboration between the Manitoba government and Bioscience Association Manitoba (BAM).
2023 BIO International Convention Booklet
This report is designed to profile our unique industry and highlight its successes, challenges, trends and future direction.
BAM 2022 Report
Financial statements for the year ended March 2022.
Bioscience Association Manitoba (BAM) and RRC Prairie Research Kitchen (PRK) held a sustainable packaging forum. Please read the following report, which discusses new innovations, obstacles, and solutions.
Bioscience Association Manitoba commissioned a study to understand and mitigate the risks to the supply chain for Personal Protective Equipment (PPE) in Manitoba.
This report is designed to profile our unique industry and highlight its successes, challenges, trends and future direction.
Financial Statements for the year ended March 31,2021
As part of the Global Biotech Week 2023 celebrations, BAM is not only celebrating the success stories within Manitoba's thriving $9.9 billion biotech industry but also taking a significant step towards securing its future.
Newly launched MY Sleep Scoring API provides free access to leading sleep analysis metric, accelerating research into the clinical management of disrupted sleep.
Provinces and territories will have access to updated COVID-19 vaccines for their respective fall vaccination campaigns
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.